Tyme Technologies, Inc. Option AgreementOption Agreement • February 2nd, 2016 • Tyme Technologies, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 2nd, 2016 Company IndustryTyme Technologies, Inc., a Delaware corporation (the “Company”), pursuant to the Company’s 2015 Equity Incentive Plan (the “Plan”), has granted to Robert Dickey IV (the “Optionee”) a stock option (the “Option”) to purchase a total of 200,000 shares (each, a “Share”) of the common stock, par value $0.0001 per share (the “Common Stock”), of the Company, at the exercise price of $11.00 per Share (the “Exercise Price”), on the terms and conditions set forth in this Option Agreement (this “Agreement”) and, in all respects, subject to the terms and conditions of the Plan. The effective date of grant of the Option is January 27, 2016 (the “Date of Grant”). Unless otherwise defined herein, the capitalized terms defined in the Plan shall have the same defined meanings in this Agreement.
Tyme Technologies, Inc. Option AgreementOption Agreement • May 20th, 2015 • Tyme Technologies, Inc. • Pharmaceutical preparations
Contract Type FiledMay 20th, 2015 Company IndustryTyme Technologies, Inc., a Delaware corporation (the “Company”), pursuant to the Company’s 2015 Equity Incentive Plan (the “Plan”), has granted to Robert Dickey IV (the “Optionee”) a stock option (the “Option”) to purchase a total of 150,000 shares (each, a “Share”) of the common stock, par value $0.0001 per share (the “Common Stock”), of the Company, at the exercise price of $7.75 per Share (the “Exercise Price”), on the terms and conditions set forth in this Option Agreement (this “Agreement”) and, in all respects, subject to the terms and conditions of the Plan. The effective date of grant of the Option is May 15, 2015 (the “Date of Grant”). Unless otherwise defined herein, the capitalized terms defined in the Plan shall have the same defined meanings in this Agreement.